Unihealth Hospitals Limited (NSE:UNIHEALTH)
India · Delayed Price · Currency is INR 725.00
+15.05 (2.12%)
Jul 13, 2026, 1:41 PM IST
Unihealth Hospitals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,320 | 990.71 | 487.5 | 439.28 | 368.32 | |
Revenue Growth (YoY) | 33.23% | 103.22% | 10.98% | 19.27% | 40.54% |
Cost of Revenue | 479.19 | 371.14 | 168.22 | 151.85 | 150.43 |
Gross Profit | 840.7 | 619.57 | 319.28 | 287.44 | 217.89 |
Selling, General & Admin | 6.55 | 7.83 | 6.82 | 4.08 | 5.06 |
Other Operating Expenses | 296.2 | 243.93 | 135.7 | 147.02 | 97.77 |
Operating Expenses | 404.6 | 311.28 | 165.15 | 176.26 | 124.96 |
Operating Income | 436.1 | 308.29 | 154.13 | 111.17 | 92.94 |
Interest Expense | -23.4 | -31.5 | -22.24 | -38.93 | -49.71 |
Interest & Investment Income | 2.92 | 11.59 | 13.79 | 5.63 | 3.52 |
Earnings From Equity Investments | 2.78 | -0.21 | -0.81 | 0.02 | -0.76 |
Currency Exchange Gain (Loss) | 38.23 | 13.67 | 1.54 | 12.13 | 5.33 |
Other Non Operating Income (Expenses) | 5.88 | 1.92 | -10.81 | 2.77 | -1.67 |
EBT Excluding Unusual Items | 462.51 | 303.75 | 135.6 | 92.8 | 49.66 |
Gain (Loss) on Sale of Assets | 3.21 | - | - | - | - |
Pretax Income | 465.72 | 303.75 | 135.6 | 92.8 | 51.28 |
Income Tax Expense | 8.46 | 32.71 | 32.56 | 16.21 | 14.11 |
Earnings From Continuing Operations | 457.26 | 271.04 | 103.04 | 76.59 | 37.17 |
Minority Interest in Earnings | -198.96 | -129.79 | 0.03 | 0.21 | 1.03 |
Net Income | 258.3 | 141.25 | 103.07 | 76.8 | 38.2 |
Net Income to Common | 258.3 | 141.25 | 103.07 | 76.8 | 38.2 |
Net Income Growth | 82.87% | 37.05% | 34.20% | 101.04% | -23.73% |
Shares Outstanding (Basic) | 15 | 15 | 13 | 11 | 11 |
Shares Outstanding (Diluted) | 16 | 15 | 13 | 11 | 11 |
Shares Change (YoY) | 1.54% | 14.54% | 21.47% | 0.00% | - |
EPS (Basic) | 16.67 | 9.17 | 7.67 | 6.94 | 3.45 |
EPS (Diluted) | 16.52 | 9.17 | 7.67 | 6.94 | 3.45 |
EPS Growth | 80.15% | 19.63% | 10.48% | 101.12% | -23.76% |
Free Cash Flow | -255.32 | -128.86 | 22.95 | -9.9 | 79.68 |
Free Cash Flow Per Share | -16.33 | -8.37 | 1.71 | -0.89 | 7.20 |
Gross Margin | 63.70% | 62.54% | 65.49% | 65.43% | 59.16% |
Operating Margin | 33.04% | 31.12% | 31.62% | 25.31% | 25.23% |
Profit Margin | 19.57% | 14.26% | 21.14% | 17.48% | 10.37% |
Free Cash Flow Margin | -19.34% | -13.01% | 4.71% | -2.25% | 21.63% |
EBITDA | 498.91 | 351.37 | 176.57 | 136.14 | 114.86 |
EBITDA Margin | 37.80% | 35.47% | 36.22% | 30.99% | 31.18% |
D&A For EBITDA | 62.81 | 43.09 | 22.43 | 24.97 | 21.92 |
EBIT | 436.1 | 308.29 | 154.13 | 111.17 | 92.94 |
EBIT Margin | 33.04% | 31.12% | 31.62% | 25.31% | 25.23% |
Effective Tax Rate | 1.82% | 10.77% | 24.01% | 17.47% | 27.52% |
Revenue as Reported | 1,370 | 1,018 | 503.53 | 460.3 | 379.27 |
Advertising Expenses | - | - | - | - | 5.06 |